NAGASE & (8012) FY2027 Q1 Earnings Report

Quick View

Executive Summary

In Q1, all segments recorded double-digit revenue growth, resulting in an increase in both revenue and profit, with the profit growth rate substantially exceeding revenue growth due to the effect of operating leverage. Revenue was ¥2797.2B (+17.9% YoY), Operating Income was ¥170.1B (+65.9%), Ordinary Income was ¥180.5B (+69.3%), and consolidated Net Income was ¥150.3B (+95.0%; of which Net Income attributable to owners of the parent was ¥146.6B, +95.2%). The primary driver of revenue growth was that all three major segments—Materials, Electronics, and Life Sciences—secured revenue growth of +17–18% YoY, while the primary driver of profit growth was an improvement in the Operating Income margin due to a decline in the SG&A ratio.

Factors Affecting Results

【Revenue】Revenue was ¥2797.2B, up +17.9% YoY. By segment, Materials was the largest at ¥1405.5B (50.2% composition ratio, YoY +18.0%), followed by Life Sciences at ¥904.4B (32.3%, +17.3%) and Electronics at ¥495.9B (17.7%, +18.0%); all three major segments recorded double-digit revenue growth. Other Businesses declined to ¥12.3B (0.4%, -24.5%), but the impact on the overall results was minor.

【Profit and Loss】Operating Income was ¥170.1B (+65.9%), and the Operating Income margin improved to 6.1% from 4.3% in the same period of the previous year, an improvement of +1.8pt. The increase in Cost of Sales (+16.4%) was below the increase in Revenue (+17.9%), lifting the gross margin to 19.7% from approximately 18.7% in the same period of the previous year. Meanwhile, SG&A expenses increased by +11.9% to ¥381.4B, resulting in an SG&A ratio of 13.6%, down -0.8pt from the previous year. As expenses were relatively contained compared with revenue growth, operating leverage became evident. Ordinary Income was ¥180.5B (+69.3%), with Non-Operating Income of ¥19.7B, including ¥10.1B in dividend income, exceeding Non-Operating Expenses of ¥9.3B, including ¥8.6B in interest expense; consequently, Ordinary Income remained above Operating Income. Extraordinary items were an Extraordinary Gain of ¥0.9B and an Extraordinary Loss of ¥0.3B, nearly neutral on a net basis, with limited impact from temporary factors. Consolidated Net Income was ¥150.3B (+95.0%), while Net Income attributable to owners of the parent was ¥146.6B (+95.2%), indicating that the improvement at the operating level was consistently reflected through to the bottom line. Accordingly, the results can be concluded to represent increases in both revenue and profit.

Segment Analysis

Beginning in Q1, the former five-segment structure was consolidated into three segments—Materials, Electronics, and Life Sciences—and the allocation method for company-wide common expenses was also revised. Materials generated Revenue of ¥1405.5B (50.2% composition ratio) and Operating Income of ¥81.9B (YoY +63.2%), with a profit margin of 5.8%, making it the largest contributor in both scale and profit. Electronics generated Revenue of ¥495.9B and Operating Income of ¥49.3B (YoY +60.4%), with a profit margin of 9.9%, demonstrating the highest profitability among the four segments and serving as the center of product-mix improvement. Life Sciences generated Revenue of ¥904.4B and Operating Income of ¥29.1B (YoY +36.6%), with a profit margin of 3.2%; revenue growth continued, but its profit margin remained below those of the other segments. Other Businesses generated Revenue of ¥12.3B and Operating Income of ¥1.2B (profit margin of 10.1%), representing a small-scale operation. The total segment profit of ¥161.6B, plus company-wide expenses and other items of +¥8.7B and adjustments of -¥0.2B, reconciles to Operating Income of ¥170.1B.

Key Financial Indicators

【Profitability】The Operating Income margin was 6.1%, improving +1.8pt from 4.3% in the same period of the previous year. The consolidated Net Income margin (¥150.3B/¥2797.2B) was 5.4%, improving +2.1pt from 3.2% in the previous year. The gross margin was 19.7%, while the SG&A ratio was 13.6% (14.4% in the previous year), indicating that greater cost-structure efficiency contributed to the improvement in profitability.【Cash Flow Quality】ROE of 3.3% represents the level obtained by simply dividing Net Income attributable to owners of the parent for the quarter of ¥146.6B by shareholders’ equity at period-end. Basic EPS increased to ¥35.93 from ¥17.40 in the previous year, an increase of +106.5%, while BPS rose to ¥1,095.74 (¥1,043.19 in the previous year).【Investment Efficiency】Total assets were ¥9421.2B, up +8.1% from ¥8715.3B in the previous year. Total asset turnover remained low, leaving room for improvement in asset efficiency relative to revenue expansion.【Financial Soundness】The Equity Ratio was 47.4%, down -1.4pt from 48.8% in the previous year. This reflected the expansion of total assets accompanied by increases in trade receivables and inventories; nevertheless, the Company continues to maintain a relatively high level of equity capital.

Cash Flow Analysis

Cash flow from operating activities was -¥212.6B, shifting to an outflow from +¥7.0B in the same period of the previous year. The primary factor was the expansion of working capital accompanying revenue growth: trade receivables absorbed ¥286.4B and inventories absorbed ¥150.3B, resulting in a substantial outflow even after partial offset from the +¥130.6B increase in trade payables. After adjusting for ¥59.3B in income taxes paid, ¥12.9B in interest received, ¥10.1B in interest paid, and other items, the final Operating Cash Flow was determined. Cash flow from investing activities was -¥41.4B, of which capital expenditures accounted for ¥34.4B; this remained below depreciation and amortization of ¥46.2B, indicating a restrained investment burden. Cash flow from financing activities was +¥181.2B, as financing through commercial paper, short-term borrowings, and other sources offset the expansion of working capital. As a result, Free Cash Flow (Operating CF + Investing CF) was -¥254.0B. Internally generated cash during the quarter was insufficient to fully cover investment and dividends, making the progress of inventory normalization and trade-receivables collection from the second half onward key to improving cash flow.

Quality of Earnings

Current-period profit consisted primarily of recurring earnings generated through operating activities, with the impact of temporary factors extremely limited, as reflected in an Extraordinary Gain of ¥0.9B and an Extraordinary Loss of ¥0.3B. The main components of Non-Operating Income of ¥19.7B were dividend income of ¥10.1B and foreign exchange gains of ¥2.4B, while the main component of Non-Operating Expenses of ¥9.3B was interest expense of ¥8.6B; Non-Operating Income and Expenses therefore provided a net positive contribution of +¥10.4B. Meanwhile, Comprehensive Income was ¥276.9B (¥270.8B attributable to owners of the parent), substantially exceeding Net Income of ¥150.3B. The primary factors behind the difference were increases in Other Comprehensive Income from foreign currency translation adjustments of +¥55.4B and valuation difference on available-for-sale securities of +¥78.5B. Because these valuation gains and losses depend on market prices and exchange-rate levels and do not represent recurring earnings power on the income statement, the divergence between Net Income and Comprehensive Income should be viewed separately as the impact of asset valuation changes. In addition, the fact that Operating CF was substantially below Net Income reflects an increase in accruals, including uncollected trade receivables and inventory accumulation; normalization of working capital is therefore a prerequisite for converting current-period profit into cash.

Earnings Forecast and Guidance

The full-year company plan calls for Revenue of ¥10000.0B (YoY +2.8%), Operating Income of ¥450.0B (YoY +0.6%), Ordinary Income of ¥450.0B (YoY +2.1%), and Net Income attributable to owners of the parent of ¥345.0B. Q1 progress rates were 28.0% for Revenue, 37.8% for Operating Income, 40.1% for Ordinary Income, and 42.5% for Net Income attributable to owners of the parent. All exceeded the simple quarterly benchmark of 25%, indicating that profit is progressing ahead of schedule. However, taking into account the impact of the situation in the Middle East and other factors, the Company plans to update its full-year earnings outlook when it announces its Q2 results after scrutinizing future market trends and demand. There were no revisions to the earnings forecast or dividend forecast for the current quarter.

Shareholder Returns

The full-year dividend forecast is ¥27.00 per share, implying a Payout Ratio of approximately 31.9% against forecast EPS of ¥84.59. As the Company conducted a 1-for-4 stock split effective April 1, 2026, and the previous-period dividend of ¥45 is stated on a pre-split basis, a simple comparison with the current-period forecast of ¥27 does not allow a determination of the effective increase or decrease in dividends. There was no revision to the dividend forecast for the current quarter, and the policy remains unchanged. No share buyback was confirmed during the quarter, and shareholder returns continue to be centered on dividends.

Risk Factors

1. Decline in cash-generation capacity due to working-capital expansion: Operating CF was -¥212.6B, primarily due to increases of ¥286.4B in trade receivables and ¥150.3B in inventories. If receivables collection and inventory optimization do not progress while revenue growth continues, improvement in cash flow may be delayed.

2. Uncertainty regarding the full-year earnings outlook: The Company has indicated that, taking into account the impact of the situation in the Middle East, it will update its full-year outlook again when announcing its Q2 results. Planned figures may be revised in response to market fluctuations.

3. Sensitivity to raw-material costs and foreign exchange fluctuations: The gross margin is relatively low at 19.7%, and the business structure is susceptible to the impact of chemical raw-material prices and foreign exchange movements on Cost of Sales and profit margins.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (trading)

Profitability and Returns

The Company’s Operating Income margin and Net Income margin both exceed the industry median, indicating that profitability is relatively high within the peer group.

Growth and Capital Efficiency

The Revenue growth rate substantially exceeds the industry median, representing a high pace of revenue growth within the industry.

※Source: Compiled by the Company

Key Takeaways from the Results

1. Combination of revenue growth and operating leverage: While all three major segments recorded double-digit revenue growth, the SG&A ratio declined to 13.6% and the Operating Income margin improved by +1.8pt. Electronics had the highest profit margin at 9.9%, making differences in segment profitability an important point for observing changes in the product mix.

2. Divergence between cash flow and profit and loss: While increases in both revenue and profit are clear from the profit-and-loss perspective, Operating CF was -¥212.6B, substantially below Net Income of ¥150.3B. The primary factors were increases in trade receivables and inventories, and the fact that profit growth has not translated directly into cash generation is an important point in assessing the quality of the results.

3. Full-year progress and planned outlook update: Although the progress rates for Operating Income and Net Income both exceed the quarterly benchmark of 25%, the Company itself has stated that it will update its full-year outlook in Q2 in light of the situation in the Middle East and other factors. Whether the plan is revised in the next disclosure will be a key point for future monitoring.

Theoretical Share Price (Reference Value)

This is a mechanically calculated reference range based solely on publicly disclosed data using a residual income model (Ohlson-type, explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥1,066–¥1,129 at ±1% for the Cost of Equity, and ¥1,097–¥1,097 at ±0.1 for ω.

Notes:

• Goodwill amortization of ¥7.6 per share is added back to profit (to account for a non-cash expense and comparability with IFRS companies).
• Because Net Income progress against the full-year forecast (42%) exceeds the standard level (25%), forecast EPS is adjusted upward within a maximum range of +10% (because companies progressing ahead of schedule tend to exceed forecasts; in businesses with strong seasonality, the adjustment may be excessive).
• Net assets as of the end of the quarter are used (there is a time lag relative to the full-year forecast).

(Calculation model: Residual Income Model / Interest-rate reference month: 2026-06 / This figure does not forecast or guarantee a future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific issue. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Nagase delivered a strong FY2027 Q1 earnings result, with revenue growth translating into materially faster operating and net-profit growth. Revenue increased 17.9% year on year to ¥279.7bn. Operating income rose 65.9% to ¥17.0bn, lifting the operating margin by 176bp to 6.1%. Ordinary income increased 69.3% to ¥18.1bn. Profit attributable to owners of parent rose 95.2% to ¥14.7bn, and the net margin expanded by 227bp to 5.2%. Gross profit increased 24.4% to ¥55.2bn, outpacing revenue and raising the gross margin by 104bp to 19.7%. SG&A expenses grew 11.9%, substantially below revenue growth, indicating favorable operating leverage. EBITDA increased to ¥21.6bn and the EBITDA margin reached 7.7%. The annualized ROE was 12.8%, placing returns within the good 10-15% range, although still below the 15% excellent benchmark. The earnings uplift was broad based across Material, Electronics and Life Science, with Electronics generating the highest segment profit margin. Net income also benefited from a relatively low 17.0% effective tax rate, while extraordinary items were immaterial. Earnings quality was the main counterweight: operating cash flow was negative ¥21.3bn despite ¥14.7bn of profit attributable to owners. The cash shortfall principally reflected a ¥286.4bn increase in trade receivables and a ¥150.3bn inventory increase, only partly offset by a ¥130.6bn increase in trade payables. Free cash flow was negative ¥254.0bn, requiring financing inflows of ¥181.2bn and reducing cash by ¥53.5bn during the quarter. Management's full-year forecast implies Q1 progress of 28.0% for revenue, 37.8% for operating income and 42.5% for profit attributable to owners, meaning profit performance is running materially ahead of a standard 25% first-quarter pace. However, the company intends to revisit guidance at the Q2 announcement after assessing Middle East-related market and demand conditions. The near-term investment case therefore depends on whether strong margins and earnings momentum can continue while receivables, inventories and operating cash conversion normalize.

Profitability Analysis

The annualized 12.8% ROE decomposes into a 5.2% net profit margin, 1.188x asset turnover and 2.07x financial leverage. Margin expansion was the principal source of improved profitability: operating margin rose to 6.1% from 4.3% a year earlier, while net margin increased to 5.2% from 3.0%. Gross margin improved to 19.7% from 18.7%, although it remains marginally below the 20% quality-alert threshold and illustrates the structurally low-margin nature of chemicals distribution and trading activities. SG&A increased 11.9%, versus 17.9% revenue growth, so the 176bp operating-margin gain also reflects positive operating leverage and cost discipline. The annualized asset turnover of 1.188x supports the return profile, but the elevated receivable and inventory intensity limits the quality of that efficiency. Annualized ROA, calculated using annualized Q1 net income and average total assets, was approximately 6.5%. The 2.07x financial leverage factor provides a meaningful contribution to ROE, but interest protection remains robust, with EBIT interest coverage of 19.75x and EBITDA interest coverage of 25.11x. Tax burden was healthy at 0.809 and interest burden exceeded 1.0x at 1.065 because non-operating income exceeded interest costs, confirming that financing costs were not a material drag on Q1 returns. Under JGAAP, goodwill amortization of ¥7.8bn reduced reported operating profit and net income; EBITDA before goodwill amortization was ¥22.4bn. Goodwill amortization was 3.6% of EBITDA, below the threshold for material cross-accounting-standard distortion. Segment profitability was led by Electronics, where segment profit increased 60.4% to ¥4.9bn and margin expanded to 9.9% from 7.3%. Material remained the core business by operating-income contribution, producing ¥8.2bn of segment profit, up 63.2%, on ¥140.3bn of revenue, up 18.0%; its segment margin improved to 5.8% from 4.2%. Life Science produced ¥2.9bn of segment profit, up 36.6%, on revenue of ¥90.2bn, up 17.4%, with margin improving to 3.2% from 2.8%.

Growth Assessment

Growth was broad based, with all three reportable segments recording double-digit revenue increases and profit growth. Material revenue rose ¥21.4bn year on year, Electronics revenue rose ¥7.6bn, and Life Science revenue rose ¥13.4bn. Material accounted for approximately 50.2% of consolidated revenue and 48.2% of segment profit before corporate costs, making it the principal earnings foundation. Electronics accounted for approximately 17.6% of revenue but 29.0% of segment profit, highlighting its superior margin structure and strategic importance to incremental earnings growth. Life Science represented approximately 32.3% of revenue and provides exposure to pharmaceuticals, food, cosmetics and healthcare end markets, although its segment margin remains lower than Electronics. The revised three-segment structure and increased delegation of authority may improve decision speed, but the recast comparative disclosure supports year-on-year comparability. Full-year revenue guidance of ¥1,000.0bn implies 2.8% growth, substantially below the Q1 growth rate, suggesting a cautious assumption for subsequent quarters. Full-year operating-income guidance of ¥45.0bn implies only 0.6% growth, while Q1 operating income already represents 37.8% of the annual target. Q1 profit attributable to owners represents 42.5% of the ¥34.5bn full-year forecast, 17.5 percentage points above standard first-quarter progress. This could indicate conservatism in the initial plan, but it also leaves scope for normalization in trading volumes, product spreads, or demand conditions. Dividend income of ¥10.1bn was a notable component of non-operating income, but operating income remained the dominant contributor to pre-tax earnings. The limited extraordinary net gain of ¥0.5bn means the earnings acceleration was predominantly recurring at the reported-profit level. Sustainable growth will be better evidenced by continued segment margin resilience and conversion of increased sales into cash rather than further working-capital accumulation.

Financial Health

Liquidity is sound based on a 180.4% current ratio, 130.1% quick ratio and ¥274.6bn of working capital. Current assets of ¥616.2bn comfortably exceeded current liabilities of ¥341.6bn, reducing near-term maturity-mismatch risk. Cash and deposits were ¥41.1bn, equivalent to 1.70x short-term loans of ¥24.1bn. Interest-bearing debt was ¥74.1bn, comprising ¥24.1bn of short-term loans and ¥50.0bn of long-term loans; commercial paper of ¥68.0bn is an additional short-term funding source reflected in financing activity and should be monitored alongside working-capital needs. The reported debt-to-equity ratio was 1.07x, below the 2.0x warning threshold but not conservative on that measure. Debt-to-capital was a modest 14.0%, and interest coverage was strong, mitigating refinancing and debt-service risk. Debt/EBITDA was 3.43x, above the 2.5x investment-grade benchmark but below the 4.0x high-yield warning level; this metric should improve if current earnings are sustained and working capital is funded efficiently. Equity increased 5.1% year on year to ¥456.1bn, supported by ¥27.7bn of comprehensive income. Accumulated other comprehensive income reached ¥124.0bn, including ¥48.3bn of valuation gains on securities and ¥73.5bn of foreign-currency translation adjustments, which makes equity partly sensitive to market valuations and exchange rates. Goodwill was ¥28.0bn, or only 6.1% of equity and 3.0% of assets, indicating low balance-sheet dependence on acquired business value. Intangible assets were 7.2% of assets, also within a balanced range. Lease obligations were ¥16.6bn and net defined-benefit liabilities were ¥11.2bn; these are manageable relative to total equity but remain fixed-claim obligations.

Notable B/S Changes

Total assets: +¥705.9bn (+8.1%) year on year to ¥9,421.2bn - growth was led by working-capital expansion and raises cash-conversion requirements. Accounts receivable: +¥327.0bn (+10.2%) to ¥3,541.3bn - receivables equal 37.6% of total assets and are consistent with the 116-day DSO warning. Inventories: +¥142.5bn (+9.0%) to ¥1,717.5bn - inventory build increased funding needs and contributes to the 70-day inventory alert. Current liabilities: +¥445.7bn (+15.0%) to ¥3,415.8bn - liabilities grew faster than current assets, though the current ratio remains healthy at 180.4%. Commercial paper: +¥210.0bn (+44.7%) to ¥680.0bn - increased short-term funding was used alongside the working-capital build and warrants rollover monitoring. Investment securities: +¥120.3bn (+13.7%) to ¥996.3bn - together with valuation gains in OCI, this increases sensitivity of equity to market-price movements. Total equity: +¥220.4bn (+5.1%) to ¥4,560.6bn - comprehensive income strengthened capital, including sizable securities valuation and foreign-currency translation effects.

Cash Flow Quality

Cash-flow quality was weak in Q1 and is the most important financial issue. Operating cash flow was negative ¥21.3bn, compared with positive ¥7.0bn in the prior-year quarter, despite profit attributable to owners increasing to ¥14.7bn. The OCF/net-income ratio was negative 1.45x, well below the 0.8x alert threshold, directly triggering the earnings-quality warning. Cash conversion, measured as OCF/EBITDA, was negative 0.98x and also materially below the 0.7x alert threshold. The principal root cause was working-capital absorption: trade receivables increased ¥286.4bn and inventories increased ¥150.3bn, while trade payables increased only ¥130.6bn. The ¥59.3bn of income taxes paid and ¥54.2bn of other operating cash-flow outflows added to the cash deficit. The 116-day DSO alert is high relative to the 60-day benchmark; in a trading and distribution model it partly reflects customer-credit and transaction-settlement structures, but it raises collection, counterparty and funding requirements. Inventory days of 70 exceed the 60-day alert threshold, indicating elevated stock commitment that may expose the group to demand shifts, price movements and inventory write-down risk. The 124-day cash conversion cycle exceeds the 120-day warning level, showing that sales growth has required substantial operating capital. The accruals ratio of 3.8% remains below the 5% high-quality benchmark, which tempers concern that accounting accruals themselves are excessive; the issue is principally balance-sheet cash absorption rather than unusually high accrual intensity. Capital expenditures were ¥3.4bn, below depreciation and amortization of ¥4.6bn, producing a 0.74x CapEx/depreciation ratio. Free cash flow was negative ¥254.0bn after capex. Financing cash flow of ¥181.2bn, including a ¥210.0bn increase in commercial paper, partly financed the operating deficit, while cash declined ¥53.5bn. Sustained negative operating cash flow would weaken funding flexibility even though current liquidity and interest coverage remain sound.

Dividend Sustainability

The full-year dividend forecast is ¥27.00 per share, while forecast EPS is ¥84.59, implying a dividend payout ratio of approximately 31.9%. This is well below the 60% sustainability benchmark and leaves substantial accounting earnings retention. The forecast dividend is therefore covered by projected earnings on a payout basis. However, Q1 free cash flow was negative ¥254.0bn because operating cash flow was negative ¥212.6bn, so first-quarter cash coverage is not currently demonstrated. Cash dividends paid during Q1 were ¥56.5bn, exceeding Q1 profit attributable to owners, which is typical where payments relate to the preceding fiscal year's distribution but reinforces the importance of full-year cash conversion. The company conducted no share repurchases in Q1, so the dividend payout ratio is the appropriate shareholder-return measure rather than a total return ratio. With a 31.9% forecast payout ratio, the key determinant of dividend resilience is not earnings coverage but whether receivable and inventory growth reverses sufficiently to restore operating cash generation. Strong liquidity, a 14.0% debt-to-capital ratio and high interest coverage provide capacity to bridge seasonal cash demands. Nevertheless, continued reliance on commercial-paper funding to finance working capital would reduce the margin of safety for distributions over time.

Risk Assessment

Business risks include Working-capital and demand risk is high: DSO of 116 days, inventory days of 70 and a 124-day cash conversion cycle expose cash generation to delayed customer collections, demand volatility and inventory price corrections., The Material segment is the core business, contributing ¥8.2bn of segment profit, so changes in chemical, resin, packaging, mobility and industrial demand can materially affect consolidated earnings., Electronics has the highest segment margin at 9.9%; semiconductor, display, battery and electronic-material cycles could therefore have an outsized effect on group margin progression., Life Science offers end-market diversification but generated a lower 3.2% segment margin, leaving profitability sensitive to product mix, input costs and execution in pharmaceutical, food and consumer-health businesses., Management cited Middle East developments as a reason to reassess market conditions and demand at Q2, creating uncertainty around energy costs, logistics, customer activity and the durability of the current earnings run-rate., Foreign-currency translation adjustments of ¥73.5bn and foreign-exchange gains indicate exposure to exchange-rate movements, which can affect overseas earnings translation and equity..

Financial risks include OCF/net income of negative 1.45x and OCF/EBITDA of negative 0.98x indicate weak Q1 cash realization of profits., Commercial paper increased by ¥210.0bn during the quarter, illustrating reliance on short-term market funding while receivables and inventory expanded., Debt/EBITDA of 3.43x is above the 2.5x investment-grade benchmark, although interest coverage of 19.75x and debt/capital of 14.0% remain supportive., Accumulated other comprehensive income includes substantial unrealized securities valuation gains and foreign-currency translation adjustments, creating potential equity volatility..

Key concerns include Highest priority: convert Q1 earnings into operating cash flow through normalization of receivables and inventories; this has both high likelihood of investor scrutiny and high impact on valuation of earnings quality., High priority: monitor whether the Q1 operating margin of 6.1% can be sustained, as full-year operating-income guidance assumes only 0.6% growth despite the strong first-quarter result., Moderate priority: assess the maturity and rollover profile of commercial paper against seasonal working-capital needs., Moderate priority: monitor Middle East-related disruptions to energy, freight, customer demand and supply chains., Low priority: goodwill impairment risk is contained because goodwill equals only 6.1% of equity and 1.29x EBITDA..

Investment Implications

Key takeaways include Q1 showed broad-based earnings acceleration: revenue grew 17.9%, operating income 65.9%, and profit attributable to owners 95.2%., Margin expansion was meaningful, with gross margin up 104bp, operating margin up 176bp and net margin up 227bp year on year., Material is the core profit contributor, while Electronics is the highest-margin segment and a key source of incremental profitability., The annualized ROE of 12.8% is solid, supported primarily by improved profit margin rather than excessive balance-sheet leverage., Negative operating cash flow and long working-capital metrics are the principal factors tempering the otherwise strong earnings result., The 31.9% forecast dividend payout ratio appears earnings-sustainable, but durable cash coverage requires a recovery in operating cash flow..

Metrics to watch include Operating cash flow, free cash flow and OCF/net income ratio, Trade receivable growth, DSO and collection trends, Inventory growth, inventory days and any valuation provisions, Commercial paper balance and short-term funding mix, Segment margins, particularly Electronics margin and Material profit contribution, Progress versus the ¥45.0bn full-year operating-income forecast and any Q2 guidance revision, Middle East-related effects on demand, energy, logistics and supply chains.

Regarding relative positioning, Nagase combines a diversified chemicals, electronics and life-science portfolio with solid liquidity, strong interest coverage and low goodwill dependence. Its annualized 12.8% ROE and 6.1% operating margin are respectable for a trading and distribution-oriented business, while Electronics provides a higher-margin growth vector. Relative to a cash-generative high-quality compounder, however, the current quarter is disadvantaged by negative cash conversion, high receivable days, elevated inventory days and dependence on short-term funding to accommodate working-capital growth.